COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. The company offers restoration products, including conventional composites, bulk-fill composites, CAD/CAM solutions, core build-ups, bondings, etching gels, temporary materials, luting, curing lights, characterizations, and parapulpal pins; and endodontics products, such as cold sprays, hand files, shaping and retreatment files, endo motors, rinsing and disinfection system, drying, temporary fillings, sealers, guttapercha points, and posts and drills. It provides prosthetics comprising bite registration, retractions, A-silicones, C-silicones, and accessories; and treatment auxiliaries consisting of dental rolls and dispensers, cotton pellets and dispensers, aspirator tips, dental dams, dental dam clamps and accessories, dental scalers, electrosurgery, and occlusion verification products. In addition, the company offers infection control products, which include ultrasonic cleaning units and solutions, patient bibs, instrument reprocessing, and surface disinfectants; rotary instruments that comprise diamond and carbide burs, polishers, kits, and accessories; and laboratory products, including gingiva masks, lab putty products, model making products, waxes, occlusion control products, and accessories. Further, it provides washers, thermal disinfection equipment, autoclaves, disinfectant wipes for dental practice surfaces, and root canal instruments. The company was formerly known as Medisize Holding AG and changed its name to COLTENE Holding AG in April 2008. COLTENE Holding AG was incorporated in 2005 and is headquartered in Altstätten, Switzerland.
Metrics to compare | CLTN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCLTNPeersSector | |
---|---|---|---|---|
P/E Ratio | 24.6x | 28.0x | −0.6x | |
PEG Ratio | −0.50 | 0.27 | 0.00 | |
Price/Book | 3.0x | 2.6x | 2.6x | |
Price / LTM Sales | 1.3x | 3.3x | 3.2x | |
Upside (Analyst Target) | 26.0% | 22.3% | 44.6% | |
Fair Value Upside | Unlock | 16.7% | 7.3% | Unlock |